Utilization of Neoadjuvant Chemotherapy Varies in the Treatment of Women with Invasive Breast Cancer

• Adedayo A. Onitilo ,

  * E-mail: onitilo.adedayo@marshfieldclinic.org

  Affiliation Department of Hematology and Oncology, Marshfield Clinic, Weston, Wisconsin, USA and Clinical Epidemiology Unit, School of Population Health, University of Queensland, Brisbane, Australia

  ⨯
• Jill K. Onesti,

  Affiliation Grand Rapids Medical Education Partners, Grand Rapids, Michigan, USA

  ⨯
• Richard M. Single,

  Affiliation University of Vermont, Burlington, Vermont, United States of America

  ⨯
• Jessica M. Engel,

  Affiliation Marshfield Clinic Cancer Care at St Michaels Hospital, Stevens Point, Wisconsin, United States of America

  ⨯
• Ted A. James,

  Affiliation University of Vermont College of Medicine, Burlington, Vermont, United States of America

  ⨯
• Erin J. Aiello Bowles,

  Affiliation Group Health Research Institute, Seattle, Washington, United States of America

  ⨯
• Heather Spencer Feigelson,

  Affiliation Kaiser Permanente Colorado, Denver, Colorado, United States of America

  ⨯
• Tom Barney,

  Affiliation Van Andel Research Institute, Grand Rapids, Michigan, United States of America

  ⨯
• Laurence E. McCahill

  Affiliation Van Andel Research Institute, Grand Rapids, Michigan, United States of America

  ⨯